Type to search

Gilead Sciences Completes Acquisition of MiroBio | Pharmtech Focus
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation | Pharmtech Focus